Corrigendum to “miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin” [J. Genet. Genom. (2017) 44, 75-84]

doi: 10.1016/j.jgg.2026.07.014

• Zitong Zhao ^a , 
• Xinyi Fan ^a , 
• Lanfang Jiang ^a , 
• Zhongqiu Xu ^b , 
• Liyan Xue ^a , 
• Qimin Zhan ^a , 
• Yongmei Song ^a    

•  

  a. State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;

•  

  b. Qiqihar Medical University, Qiqihar 161000, China